medigraphic.com
SPANISH

Cirugía Cardiaca en México

ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 2

Next >>

Cir Card Mex 2022; 7 (2)

Left Main Coronary Artery Disease in the new 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A word of criticism

García-Villarreal OA
Full text How to cite this article

Language: English
References: 6
Page: 21-22
PDF size: 129.98 Kb.


Key words:

Clinical practice guideline, Coronary artery disease, Coronary artery bypass grafting, Left main coronary stenosis, Surgery.

Text Extraction

Much attention has been lately focused on the importance of using ever-increasing less invasive approaches to treat heart diseases. In view of PCI being an off-pump procedure, it is imperative that we increase our understanding of it, by studying the correct meta-analyses designed for this purpose. In addition, it is almost inevitable that in an era of reliance on technology as an important adjunct as trouble shooter, coupled with any potential bias, that there is a need to examine a comprehensive view of the new 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.
Every effort should be made to fully consider all the implications and effects of the several Classes of Recommendation (COR) contained in this new Guideline. The magnitude of change in the use of this kind of technology, such as PCI recommended by this Guideline, will set a pattern for the manner in which coronary artery disease (CAD) will be approached in the upcoming years.


REFERENCES

  1. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM,Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, GoldbergerZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC,Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the AmericanCollege of Cardiology/American Heart Association Joint Committee on ClinicalPractice Guidelines. Circulation. (2021):CIR0000000000001038. doi: 10.1161/CIR.0000000000001038.

  2. Bittl JA, He Y, Jacobs AK, Yancy CW, Normand SL; American College of CardiologyFoundation/American Heart Association Task Force on Practice Guidelines.Bayesian methods affirm the use of percutaneous coronary intervention to improvesurvival in patients with unprotected left main coronary artery disease. Circulation.2013;127(22):2177-85. doi: 10.1161/CIRCULATIONAHA.112.000646.

  3. Ye Y, Zhang S. Letter by Ye and Zhang regarding article, "Bayesian methods affirmthe use of percutaneous coronary intervention to improve survival in patients withunprotected left main coronary artery disease". Circulation. 2014;129(4):e307.doi: 10.1161/CIRCULATIONAHA.113.004523.

  4. Diamond GA. Letter by Diamond regarding article, "Bayesian methods affirm theuse of percutaneous coronary intervention to improve survival in patients with unprotectedleft main coronary artery disease". Circulation. 2014;129(4):e308. doi:10.1161/CIRCULATIONAHA.113.004321.

  5. Brophy JM. Bayesian Interpretation of the EXCEL Trial and Other RandomizedClinical Trials of Left Main Coronary Artery Revascularization. JAMA InternMed. 2020;180(7):986-992. doi: 10.1001/jamainternmed.2020.1647.

  6. García-Villarreal OA. Professional Medical Liabitity, Lex Artis, Medical Malpractice,and Guidelines for the Clinical Practice. The importance of adhering to thecurrent Clinical Guidelines in the daily practice. Cir Card Mex 2021; 6(3): 75-8.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Card Mex. 2022;7